BCRX
#1853
BioCryst Pharmaceuticals, Inc. - Common Stock
9.7 4 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.72%
Monthly Change
+11.19%
6 month change
+44.08%
Year Change
+8.22%
Previous Close
9.9 1
Open
9.8 0
Low
9.7 3
High
9.8 3
Volume
1 463
Financials
- Market Capitalization 2.48 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
6.45
Price to sales ratio
1.95
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1835 |  IMNM Immunome, Inc. - Common Stock | 22.59 USD | -0.92% | -7.38% | +21.26% | +163.90% | 2.56 B USD | ||
| 1846 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.91 USD | +8.41% | -8.15% | +24.29% | +154.77% | 2.54 B USD | ||
| 1860 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.37 USD | +5.94% | -0.96% | +69.24% | +578.68% | 2.49 B USD | ||
| 1868 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 56.11 USD | -5.40% | -20.47% | -9.62% | -15.06% | 2.41 B USD |
Frequently asked questions about BioCryst Pharmaceuticals, Inc. - Common Stock
What is the BioCryst Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) is 9.74. Over the past 24 hours, the stock has changed by -1.72%. Follow the BCRX chart for real-time price dynamics.
What is the stock ticker of BioCryst Pharmaceuticals, Inc. - Common Stock?
BioCryst Pharmaceuticals, Inc. - Common Stock trades under the ticker BCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioCryst Pharmaceuticals, Inc. - Common Stock stock going up?
BCRX has changed by -11.37% over the last week, +11.19% over the last month, and +8.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioCryst Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
BioCryst Pharmaceuticals, Inc. - Common Stock reported net income of -721.81 M for the last quarter. The previous quarter showed 245.84 M, which means net income changed by -393.60%.
How many employees does BioCryst Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, BioCryst Pharmaceuticals, Inc. - Common Stock has 435 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioCryst Pharmaceuticals, Inc. - Common Stock EBITDA?
BioCryst Pharmaceuticals, Inc. - Common Stock EBITDA is -700.16 M, and its EBITDA margin is -447.64%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioCryst Pharmaceuticals, Inc. - Common Stock stock?
You can buy BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioCryst Pharmaceuticals, Inc. - Common Stock stock?
Investing in BioCryst Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCRX chart and related analysis on metatrader.com as part of your research.